Mitchell L Fahning

5PUBLICATIONS
46CO-AUTHORS
AutoimmunityHaematological tumoursRegenerative medicine (incl. stem cells)Nanofabrication, growth and self assembly
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 04, 2026
The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity.

|Dec 22, 2025
The altered T cell landscape in Systemic Sclerosis patients is characterized by dysfunctional type 1 immunity.

Victoria Volfson-Sedletsky, Hannah A DeBerg, Mitch L Fahning

|Aug 12, 2024
T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts.

Hannah A DeBerg, Mitch L Fahning, Suraj R Varkhande

|Mar 15, 2022
Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.

Yevgeniy Yuzefpolskiy, Peter Morawski, Mitch Fahning

|Apr 02, 2021
Designed proteins assemble antibodies into modular nanocages.

Robby Divine, Ha V Dang, George Ueda

Pageof 1

Frequent Collaborators

5 joint publications

Peter Morawski

5 joint publications

Daniel J Campbell

3 joint publications

Hannah A DeBerg

2 joint publications

Anna C Belkina